The Foundation for Orthopaedics and Regenerative Medicine
Stem cell treatment has shown efficacy for PCOS in both human and animal studies. Complete resolution was seen of polycystic ovary syndrome (PCOS) in a young woman after a single intravenous injection of umbilical cord or placental derived mesenchymal stem cells (MSC). It is hypothesized that intravenous infusion of MSC can reduce or eliminate PCOS. Hormone levels and ultrasound will be checked 3,6 and 12 months after treatment.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Ultrasound documented poly cystic ovary syndrome
You may not be if
Active infection
Active cancer
Chronic multisystem organ failure
Pregnancy
Clinically significant abnormalities on pre-treatment laboratory evaluation
Medical condition that would (based on the opinion of the investigator) compromise patient's safety
